Comparing Abilify Asimtufii vs Lumateperone
| Abilify Asimtufii (aripiprazole) | Lumateperone |
|
|---|
| Abilify Asimtufii (aripiprazole) | Lumateperone |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Bipolar Disorder, Schizophrenia. Abilify Asimtufii may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Bipolar Disorder, Schizophrenia. Lumateperone may also be used for purposes not listed in this medication guide. |
Related suggestions Schizophrenia
|
|||||||
| More about Abilify Asimtufii (aripiprazole) | More about Lumateperone | ||||||||
| Ratings & Reviews | |||||||||
|
Abilify Asimtufii has an average rating of 8.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Lumateperone has an average rating of 6.6 out of 10 from a total of 188 ratings on Drugs.com. 56% of reviewers reported a positive effect, while 29% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
|
View all Abilify Asimtufii side effects |
View all Lumateperone side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
N/A |
|||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
View all Abilify Asimtufii prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | |||||||||
|
N/A |
||||||||
| Brand Names | |||||||||
| Other aripiprazole brands include: Abilify, Abilify Maintena, Abilify MyCite, Aristada, Aristada Initio, Mezofy, Opipza | Caplyta | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
146 hours |
18 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 732 drugs are known to interact with Abilify Asimtufii:
|
A total of 605 drugs are known to interact with Lumateperone:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
|||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
April 27, 2023 |
N/A |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Rexulti
Rexulti (brexpiprazole) is a prescription antipsychotic medication used in the treatment of major ...
Vraylar
Vraylar is a once a day antipsychotic medication used to treat mental health or mood disorders ...
Caplyta
Caplyta (lumateperone) may be used to treat schizophrenia or depression associated with bipolar ...
Abilify
Abilify is an antipsychotic medicine used to treat the symptoms of schizophrenia and bipolar ...
Seroquel
Seroquel is used to treat the symptoms of schizophrenia, bipolar disorder and major depressive ...
Lamictal
Lamictal is an anti-epileptic medication used treat seizures in adults and children over 2 years ...
Depakote
Depakote is used to treat various types of seizure disorders. Learn about side effects ...
Zyprexa
Zyprexa (olanzapine) is an atypical antipsychotic that may be used to treat adults and adolescents ...
Latuda
Latuda information from Drugs.com, includes Latuda side effects, interactions and indications.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.